Wireless’ deep brain stimulation technique offers promising potential for neurodegenerative diseases BEIJING — Parkinson’s ...

With just over 100 days as CEO now under her belt, Catherine Owen Adams is looking to cruise rare disease-focused Acadia ...

Parkinson's disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction.

This insightful interactive webinar delves into the motor and non-motor symptoms experienced by patients with Parkinson’s ...

Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms of Parkinson's disease in Amsterdam this week, Amsterdam UMC reported. The ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

In Episode 746 of Power Athlete Radio, Dr. Adeel Khan dives into cutting-edge advancements in regenerative medicine, focusing on induced pluripotent stem cells ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

Researchers at New York’s Mount Sinai Hospital have developed a cutting-edge AI-powered algorithm which could aid in the ...